Study

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. – Cost Effective Supplements

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/20427778


Conclusion of this study

Vitamin E was superior to placebo for the treatment of nonalcoholic steatohepatitis in adults without diabetes. There was no benefit of pioglitazone over placebo for the primary outcome; however, significant benefits of pioglitazone were observed for some of the secondary outcomes. (ClinicalTrials.gov number, NCT00063622.)


Supplements analyzed in this study

Vitamin E

Health conditions analyzed in this study

Cirrhosis


Slightly Positive
Vitamin E

Fatty Liver Disease


Slightly Positive
Vitamin E


Functions related to this study

Detox


Moderately Positive
Vitamin E


Body systems related to this study


Digestive System
Scroll to top